Not Yet Recruiting Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592 Conditions Alpha1 Antitrypsin Deficiency, Alpha1-Proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more Locations Not specified View Trial Details
